Similar to Tregs, the TNF-TNFR2 axis also promotes the activation and suppression of MDSCs in tumor progression by several mechanisms such as promoting secretion of nitric oxide (NO), IL-10 and TGF-β as well as enhancing the inhibition of lymphocyte proliferation (93, 94). The gene discussed is TNFRSF1B; the disease is neoplasm.